UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks

British journal of dermatology (1951), 2007-12, Vol.157 (6), p.1275-1277

2007

Volltextzugriff (PDF)

Effect of concomitant statins on rituximab efficacy in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2014-10, Vol.73 (10), p.1906-1908

2014

Volltextzugriff (PDF)

FRI0200 Incident Malignancies Following Initiation of Rituximab for Rheumatoid Arthritis: Analysis from The Sunstone Registry

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.503-503

2016

Volltextzugriff (PDF)

FRI0298 Treatment Patterns among Adult Systemic Sclerosis Patients in A US Healthcare Claims Population

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.543-543

2016

Volltextzugriff (PDF)

FRI0268 Safety and Efficacy of Subcutaneous Tocilizumab in Early Systemic Sclerosis: Results from The Open-Label Period of The Fasscinate Trial

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.531-532

2016

Volltextzugriff (PDF)

Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial

British journal of dermatology (1951), 2005-12, Vol.153 (6), p.1192-1199

2005

Volltextzugriff (PDF)

OP0054 Safety and Efficacy of Subcutaneous Tocilizumab in Adults with Systemic Sclerosis: Week 48 Data from the Fasscinate Trial

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.87-88

2015

Volltextzugriff (PDF)

Integrated safety in tocilizumab clinical trials

Arthritis research & therapy, 2011-01, Vol.13 (5), p.R141-R141

2011

Volltextzugriff (PDF)

Urinary Iodine, Perchlorate, and Thiocyanate Concentrations in U.S. Lactating Women

Thyroid (New York, N.Y.), 2017-12, Vol.27 (12), p.1574-1581

2017

Volltextzugriff (PDF)

Environmental perchlorate and thiocyanate exposures and infant serum thyroid function

Thyroid (New York, N.Y.), 2012-09, Vol.22 (9), p.938-943

2012

Volltextzugriff (PDF)

Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasis

British journal of dermatology (1951), 2007-01, Vol.156 (1), p.138-142

2007

Volltextzugriff (PDF)

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

The Lancet (British edition), 2006-01, Vol.367 (9504), p.29-35

2006

Volltextzugriff (PDF)

SARS-CoV-2 Infection During Pregnancy

Deutsches Ärzteblatt international, 2022-09, Vol.119 (35-36), p.588-594

2022

Volltextzugriff (PDF)

SAT0158 EFFICACY AND SAFETY OF FILGOTINIB IN METHOTREXATE-NAÏVE PATIENTS WITH RHEUMATOID ARTHRITIS: FINCH 3 52-WEEK RESULTS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1019-1020

2020

Volltextzugriff (PDF)

THU0198 EFFICACY AND SAFETY OF FILGOTINIB FOR PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO METHOTREXATE: FINCH 1 52-WEEK RESULTS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.320-321

2020

Volltextzugriff (PDF)

Limited Applicability of GW9662 to Elucidate PPARγ-Mediated Fatty Acid Effects in Primary Human T-Helper Cells

International Journal of Inflammation, 2014-01, Vol.2014 (2014), p.11-16

2014

Volltextzugriff (PDF)

Efficacy of etanercept in an integrated multistudy database of patients with psoriasis

Journal of the American Academy of Dermatology, 2006-03, Vol.54 (3), p.S101-S111

2006

Volltextzugriff (PDF)

Effects of two novel cationic staphylococcal proteins (NP-taseand p70) and enterotoxin B on IgE synthesis and interleukin-4 and interferon-γ production in patients with atopic dermatitis

British journal of dermatology (1951), 2000-04, Vol.142 (4), p.680-687

2000

Volltextzugriff (PDF)

ECM et TEV dans le développement clinique du filgotinib dans la polyarthrite rhumatoïde : analyse intégrée des essais cliniques de phases 2 et 3

Revue du rhumatisme (Ed. française : 1993), 2021-12, Vol.88, p.A111-A112

2021

Volltextzugriff (PDF)

Etanercept monotherapy in patients with psoriasis: A summary of safety, based on an integrated multistudy database

Journal of the American Academy of Dermatology, 2006-03, Vol.54 (3), p.S92-S100

2006

Volltextzugriff (PDF)

Etanercept improves the health-related quality of life of patients with psoriasis: Results of a phase III randomized clinical trial

Journal of the American Academy of Dermatology, 2005-11, Vol.53 (5), p.887-889

2005

Volltextzugriff (PDF)

CD40L Blockade Prevents Autoimmune Diabetes by Induction of Bitypic NK/DC Regulatory Cells

Immunity (Cambridge, Mass.), 2002-03, Vol.16 (3), p.403-415

2002

Volltextzugriff (PDF)

Efficacité et tolérance du filgotinib chez les patients atteints de polyarthrite rhumatoïde (PR) présentant une réponse inadéquate au méthotrexate (RI-MTX) : résultats de l’étude FINCH 1 à 52 semaines

Revue du rhumatisme (Ed. française : 1993), 2020-12, Vol.87, p.A18-A19

2020

Volltextzugriff (PDF)

Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy

The Journal of dermatological treatment, 2006, Vol.17 (1), p.9-17

2006

Volltextzugriff (PDF)

Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trial

Journal of the American Academy of Dermatology, 2006-03, Vol.54 (3), p.S112-S119

2006

Volltextzugriff (PDF)

1 – 25 von 572

Suche als RSS-Feed

Aktive Filter

ThemaDiet

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(399)
Mit Volltextzugriff
(401)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(299)
Life Sciences & Biomedicine
(267)
Humans
(159)
Female
(104)
Animals
(97)
Biological And Medical Sciences
(96)
Male
(90)
Biochemistry & Molecular Biology
(71)
Fundamental And Applied Biological Sciences. Psychology
(67)
Nutrition & Dietetics
(64)
Adult
(59)
Physical Sciences
(45)
Medical Sciences
(42)
Middle Aged
(42)
Double-Blind Method
(39)
Chemistry
(34)
Food Science & Technology
(33)
Fatty Acids
(27)
Aged
(25)
Mice
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks

Effect of concomitant statins on rituximab efficacy in patients with rheumatoid arthritis

FRI0200 Incident Malignancies Following Initiation of Rituximab for Rheumatoid Arthritis: Analysis from The Sunstone Registry

FRI0298 Treatment Patterns among Adult Systemic Sclerosis Patients in A US Healthcare Claims Population

FRI0268 Safety and Efficacy of Subcutaneous Tocilizumab in Early Systemic Sclerosis: Results from The Open-Label Period of The Fasscinate Trial

Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial

OP0054 Safety and Efficacy of Subcutaneous Tocilizumab in Adults with Systemic Sclerosis: Week 48 Data from the Fasscinate Trial

Integrated safety in tocilizumab clinical trials

Urinary Iodine, Perchlorate, and Thiocyanate Concentrations in U.S. Lactating Women

Environmental perchlorate and thiocyanate exposures and infant serum thyroid function

Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasis

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

SARS-CoV-2 Infection During Pregnancy

SAT0158 EFFICACY AND SAFETY OF FILGOTINIB IN METHOTREXATE-NAÏVE PATIENTS WITH RHEUMATOID ARTHRITIS: FINCH 3 52-WEEK RESULTS

THU0198 EFFICACY AND SAFETY OF FILGOTINIB FOR PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO METHOTREXATE: FINCH 1 52-WEEK RESULTS

Limited Applicability of GW9662 to Elucidate PPARγ-Mediated Fatty Acid Effects in Primary Human T-Helper Cells

Efficacy of etanercept in an integrated multistudy database of patients with psoriasis

Effects of two novel cationic staphylococcal proteins (NP-taseand p70) and enterotoxin B on IgE synthesis and interleukin-4 and interferon-γ production in patients with atopic dermatitis

ECM et TEV dans le développement clinique du filgotinib dans la polyarthrite rhumatoïde : analyse intégrée des essais cliniques de phases 2 et 3

Etanercept monotherapy in patients with psoriasis: A summary of safety, based on an integrated multistudy database

Etanercept improves the health-related quality of life of patients with psoriasis: Results of a phase III randomized clinical trial

CD40L Blockade Prevents Autoimmune Diabetes by Induction of Bitypic NK/DC Regulatory Cells

Efficacité et tolérance du filgotinib chez les patients atteints de polyarthrite rhumatoïde (PR) présentant une réponse inadéquate au méthotrexate (RI-MTX) : résultats de l’étude FINCH 1 à 52 semaines

Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy

Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trial

Aktive Filter

Suchergebnisse filtern